Navigation Links
Lithium May help in Alzheimer's Disease

Alzheimer's affects about 12 million people worldwide. Lithium may have a potential role in treating Alzheimer's. Lithium targets an enzyme called GSK-3 that facilitates the modification of both the proteins found in Alzheimer's patients. Identification of GSK-3 as a target could help in developing other drugs that disrupt the production of both proteins.

Another advantage to lithium is that it does not disrupt the processing of another protein called notch, as do other potential Alzheimer's drugs. Notch is vital for the production of blood cells.
The drug has been used for decades to treat manic depression. //Alzheimer's is marked by the buildup in the brain of one protein, called amyloid beta, outside nerve cells and a second, called tau, that forms tangles in the cells. Many scientists believe that the accumulation of amyloid beta causes the debilitating effects of the memory-robbing disease.

The recent issue of the journal Nature has reported that in mice experiments, Lithium blocks the production of proteins that form deposits in the brains of Alzheimer's patients. Lithium, though widely used to treat mental problems does have many side effects, including kidney damage.
"Potentially, lithium could be used to reverse both the pathological features of Alzheimer's disease," said Dr. Peter Klein of the University of Pennsylvania who co-authored the current study. "It seems you could block with a single medicine both of the major structural manifestations of the disease. This would be the first time that has been shown," said Dr. Sam Gandy, director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia.

Klein and his colleagues overproduce a protein that when modified forms amyloid beta in mice. The mouse experiments showed that lithium disrupts that modification process. They also showed that lithium disrupts the modification of tau. Currently it is unclear what role tau plays i n cellsin the progression of Alzheimer's.

Alzheimer's disease usualy starts at the age of 60 years and involves the parts of the brain that control thought, memory, and language. At present we do not know what causes Alzheimer's and there is no cure.

Related medicine news :

1. High Doses of Lithium-Like Drugs May Impair Neuronal Function
2. Lithium Increases Gray Matter in Bipolar Brains
3. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
4. Decrease in testosterone levels lead to Alzheimers
5. Smokers are prone to Alzheimers
6. Over-The-Counter Drugs May Prevent Alzheimers
7. Alzheimers followed by head injury
8. Vitamin E useful for Alzheimers
9. Staying mentally energitic prevents Alzheimers
10. Researchers trick Alzheimers Enzyme
11. Drug Offers Hope for Alzheimers disease
Post Your Comments:

(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: